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INTRODUCTION
The incidence of vestibular schwannomas is estimated to be 13–20 per million [1, 2]. The diagnostic work-up to determine or 
exclude vestibular schwannoma (or cerebellopontine angle lesion in general) has evolved over the years. Several studies have 
been conducted on this. Before the invention of magnetic resonance imaging (MRI), auditory brainstem responses (ABRs) and 
computed tomography (whether or not with contrast enhancement) were the gold standard. Studies conducted in 1990s and 
early 2000s were focused on establishing the role of MRI, which is to perform an MRI scan rather than an ABR test [3-5]. Once the 
superiority of MRI was proven, the widespread availability and ever improving image quality of MRI in the Western world has 
led to a remarkable shift in the diagnostic model of performing imaging when a cerebellopontine angle process is actually ex-
pected toward the more defensive attitude of “excluding a cerebellopontine angle lesion,” gradually increasing the sensitivity 
(a sensitivity of 100% indicates that all lesions are found upon imaging) of a used algorithm (if any) to perform an MRI scan. A 
recent estimation is that, currently, only 1.09–5.23% (specificity) of all MRI scans performed for asymmetric hearing loss leads to 
the detection of vestibular schwannoma [6-8].
Traditionally, mostly (the degree of ) asymmetric hearing loss has been subject to the discussion of when to perform an MRI scan, 
and this is what mainly will be discussed here. Several audiometric criteria (or “protocols”) have been proposed to standardize 
the indications to perform an MRI scan, varying from very selective and strict to broad criteria. Moreover, the tendency to per-
form imaging depends on the hospital setting, local traditions, associated symptoms, patients’ age, and comorbidity and is also 
subject to the perseverance of the patient and gut feeling of the physician.
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Currently, cerebellopontine angle tumor and, more specifically, vestibular schwannoma is diagnosed using magnetic resonance imaging (MRI). 
The main reason to perform an MRI scan is to determine asymmetrical sensorineural hearing loss. The extent of asymmetry differs in the presen-
tation of vestibular schwannoma, making it difficult to determine when to perform imaging diagnostics. Several studies have determined the 
probability of the presence of a cerebellopontine angle lesion using different audiological protocols. Further, there is also a cost aspect: what are 
the accepted sensitivity and specificity of these protocols? In this study, we reviewed the existing protocols.
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Apart from asymmetric hearing loss, tinnitus, unilateral peripheral 
vestibulopathy not explained otherwise (rather function loss than 
paroxysmal vertigo), co-existing trigeminal neuropathy, or a combi-
nation of these symptoms can be reasons to perform an MRI scan. 
Because these are more dichotomous outcome measures (or prob-
ably because hearing can be measured more accurately), there has 
been no discussion regarding these symptoms in previous studies.
EVIDENCE
There is no prospective research available on this topic. However, 
there are studies regarding the specificity and sensitivity of differ-
ent proposed audiometric algorithms. Different studies describing 
audiological protocols that are used to allocate to screening using 
MRI were all reviewed and are mentioned in the evidence table. 
Cheng et al. [8] reviewed and compared the specificity and sensitiv-
ity of available algorithms by retrospectively applying them on a 
large cohort (n=1751) of patients [3, 9-20]. It was a high-quality study 
facilitating the discussion on choosing the ideal audiological proto-
col, which is used as the basis of the evidence table. An important 
disadvantage of that  study is the lack of translation into terms of 
cost-effectiveness. It is useful to know about the most sensitive pro-
tocol, for example, for use in a tertiary referral center, and the more 
specific protocols in countries without ample financial resources, 
but a reasonable compromise between good sensitivity on the 
one hand and screening on the other hand is what would be the 
most useful in the daily practice of most physicians dealing with 
this problem. Gimsing et al. [21] proposed a protocol that provides 
these criteria. They noted that “in clinical work, it is important to 
consider another aspect of specificity, namely the proportion of pa-
tients that each protocol will allocate to screening”. The proposed 
protocol was (1) ≥20 dB asymmetry at two neighboring frequencies 
or unilateral tinnitus or (2) ≥15 dB asymmetry at two frequencies 
between 2 and 8 kHz. In the present study, eight different study 
protocols were retrospectively tested on 424 patients [9, 10, 14, 15, 17-20], 
with the diagnosis established (tumor/no tumor). Depending on 
the criteria used, the amount of “false-negative” patients (tumor, 
but no MRI performed) and “false-positive” patients (no tumor, 
but MRI performed) differs. Each protocol has a certain sensitivity 
and specificity. The higher the sensitivity, the more schwannomas 
are diagnosed. The higher the specificity,  the less schwannomas 
would be missed. Moreover, there is a (related) screening rate, i.e., 
the fraction of audiograms that allocate to perform an MRI scan, 
varying from 18% to 35% (prospectively analyzed for a cohort of 
210 patients by Gimsing et al. [21]). This is directly related to the costs 
of screening. An American study has estimated the average cost of 
diagnosing one patient with vestibular schwannoma as US$61,650 
(retrospective chart review, no specific audiological protocol used) 
[22]. If the abovementioned fraction of 1%–5% is used (the percent-
age of MRI scans that lead to the diagnosis of vestibular schwan-
noma), this would lead to an average cost of €10,000–€40,000 per 
diagnosed schwannoma (price of an MRI scan set at €400) [6-8].
A recent diagnostic review and meta-analysis was performed to 
specifically investigate the diagnostic accuracy (defined as the op-
timal combination of sensitivity and specificity) of these screening 
protocols [23]. It concluded that most studies were of poor-to-mod-
erate quality. Results of five pure-tone audiometry protocols, which 
have been frequently proposed in literature, were pooled [13, 20, 21]. 
The highest diagnostic accuracy was achieved by the protocol 
established by the AAO-HNS, which prescribes an MRI scan for 
patients with an average asymmetry of ≥15 dB on 0.5-3 kHz fre-
quencies. Its sensitivity and specificity reached 90.9% and 57.5%, 
respectively. However, 3 kHz (used n this protocol) is generally not 
included in standard audiometry. The protocol described by Seattle 
et al. prescribes an MRI scan for patients with an average asymme-
try of ≥15 dB on frequencies 1-8 kHz (excluding the 3 kHz frequen-
cy) and reaches a slightly lower sensitivity and specificity of 89.2% 
and 43.8%, respectively. None of the described screening protocols 
could diagnose all patients with vestibular schwannoma.
Other audiological findings are worse predictors than audiograms. 
Absent stapedial reflexes occur more or less equally in patients with 
vestibular schwannoma and those without any tumor. The loss of 
speech discrimination more frequently occurs in patients with ves-
tibular schwannoma; however, several patients have a loss of <10% 
[21]. Vestibular schwannoma occurs in 4% of patients with sudden 
sensorineural hearing loss [24]. Furthermore, Gimsing et al. [21] eval-
uated the shape of the audiogram and found no strong associa-
tion of the shape of the audiogram with the presence of vestibular 
schwannoma; however, there might be a minimal predilection for a 
flat-shaped audiogram.
An interesting and promising study described the possibility of a 
computerized technique in predicting and, therefore, allocating 
for MRI screening using audiological and MRI data on a group of 
patients without vestibular schwannoma [9]. A so-called Gaussian 
process ordinal regression classifier was used to determine and 
predict the presence of vestibular schwannoma. With 129 patients, 
the program achieved a sensitivity and specificity of 95% and 56%, 
respectively (30% better than audiological protocols with a similar 
sensitivity). Patient age, the presence of vertigo, and unilateral tin-
nitus were also taken into account.
CONCLUSION
No prospective studies answering this research question are avail-
able; however, there is a series of useful retrospective studies. 
Eventually, the position of the clinician or, in this case, the EAONO 
is based on the balance between minimal sensitivity on the one 
hand and maximal cost on the other hand. The optimal protocol 
still depends on the setting of the clinician and the availability of 
resources.
Remarks
This text comprises a summary of available retrospective studies in 
this field of research. Please realize that there is no single prospec-
tive study whatsoever that covers this research question. However, 
the pragmatic answer can be found by testing different audiologi-
cal protocols on cohorts of patients with available audiological and 
MRI data retrospectively. Therefore, the systematic reviewing of lit-
erature becomes less interesting. Therefore, the text format might 
be less GRADE-compatible than initially intended.
Moreover, one important thing not been taken into account, i.e., the 
likelihood to act on a positive finding on an MRI scan. Ever since the 
increasing availability of MRI scans, the size of vestibular schwan-
nomas at the time of diagnosis has dramatically decreased. Simul-
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taneously, there is widespread evidence that conservative policy 
for small- and medium-sized tumors is often the most favorable, 
particularly in the elderly. €40,000 for a diagnosis that most prob-
ably will remain untreated (not to mention the follow-up scans) is 
quite a burden on health expenses. Whether this advocates more 
strict rules to perform an MRI scan in the first place remains to be 
investigated. The unwanted side effect of a more strict protocol 
would perhaps be to miss different pathologies in the cerebello-
pontine angle. Assuming that different (possibly malignant) etiol-
ogies would generally be associated with a faster deterioration of 
hearing, would there be a place for repeated audiometry again, just 
like in earlier days?
Position of EAONO
The best audiological protocol to allocate for MRI screening for ves-
tibular schwannoma is subject to the setting in which it is used, and 
the discussion is ongoing regarding its sensitivity and specificity 
and the related costs. The EAONO advises to follow the following 
algorithm:
The proposed protocol:
(1) ≥20 dB asymmetry at two neighboring frequencies or unilateral 
tinnitus
(2) ≥15 dB asymmetry at two frequencies between 2 and 8 kHz
More sensitive protocols are optional but will obviously lead to 
higher costs. In a tertiary referral center, a protocol with a very high 
sensitivity is justified.
Apart from audiological protocols, the EAONO encourages the idea 
of a computerized “self-learning” algorithm that uses audiological 
and other (dichotomous) data to predict the presence of vestibular 
schwannoma. A large-scale prospective multicenter study with this 
program would be highly valuable and, perhaps, the key to cost-ef-
fectiveness while keeping sensitivity rates acceptable. In contrast, 
the probability of the treatment of (elderly) patients with positive 
MRI findings should be taken into account.
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Editor’s Note:
The EAONO Project on guidelines of Otology and Neurotology was initiated 
by Franco Trabalzini and the Working Groups began working in 2011. Since 
then a considerable work has been issued to produce the first Consensus 
Documents.
The working Group on Vestibular Schwannoma have esteemed members 
from dedicated centers all over Europe. I wish to express my thanks to the 
working group leaders Miguel Aristegui and Jacques Magnan for their great 
effort as well as to all the other active members of the group. 
Miguel Aristegui, Shakeel Saeed, Simon Lloyd, Per-Caye Thomasen and 
Jacques Magnan’s comments for this “Consensus Document” have been 
very much appreciated.
This study is very much respected by the Editorial of the Journal in this regard.
Prof. Dr. O. Nuri Ozgirgin
Editor in Chief   
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